Human Cytochrome P450 and Personalized Medicine

被引:8
|
作者
Chen, Qi [1 ]
Wei, Dongqing [1 ]
机构
[1] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Coll Life Sci & Biotechnol, Shanghai 200030, Peoples R China
来源
关键词
Personalized medicine; SNPs; CYP450; SINGLE NUCLEOTIDE POLYMORPHISMS; CONGENITAL ADRENAL-HYPERPLASIA; DRUG; DISCOVERY; PHARMACOGENETICS; SCHIZOPHRENIA; WARFARIN; GENE;
D O I
10.1007/978-94-017-9245-5_20
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Personalized medicine has become a hot topic ascribed to the development of Human Genome Project. And currently, bioinformatics methodology plays an essential role in personal drug design. Here in this review we mainly focused on the basic introduction of the SNPs of human drug metabolic enzymes and their relationships with personalized medicine. Some common bioinformatics analysis methods and latest progresses and applications in personal drug design have also been discussed. Thus bioinformatics studies on SNPs of human CYP450 genes will contribute to indicate the most possible genes that are associated with human diseases and relevant therapeutic targets, identify and predict the drug efficacy and adverse drug response, investigate individual gene specific properties and then provide personalized and optimal clinic therapies.
引用
收藏
页码:341 / 351
页数:11
相关论文
共 50 条
  • [21] Recombinant baculovirus strategy for coexpression of functional human cytochrome P450 and P450 reductase
    Lee, CA
    Kost, TA
    SerabjitSingh, CJ
    CYTOCHROME P450, PT B, 1996, 272 : 86 - 95
  • [22] Design of a novel P450: A functional bacterial-human cytochrome P450 chimera
    Shimoji, M
    Yin, HQ
    Higgins, LA
    Jones, JP
    BIOCHEMISTRY, 1998, 37 (25) : 8848 - 8852
  • [23] Human Cytochromes P450: Focus on Cytochrome P450 2C19
    Zvyaga, Tatyana
    Chang, Shu-Ying
    Chen, Cliff
    Yang, Zheng
    Vuppugalla, Ragini
    Hurley, Jeremy
    Thorndike, Denise
    Wagner, Andrew
    Chimalakonda, Anjaneya
    Rodrigues, A. David
    DRUG METABOLISM AND DISPOSITION, 2012, 40 (09) : 1698 - 1711
  • [24] Membrane Anchor of Cytochrome P450 Reductase Suppresses the Uncoupling of Cytochrome P450
    Miyamoto, Masayoshi
    Yamashita, Taku
    Yasuhara, Yuki
    Hayasaki, Akinori
    Hosokawa, Yukari
    Tsujino, Hirofumi
    Uno, Tadayuki
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2015, 63 (04) : 286 - 294
  • [25] In vitro effects of tacrolimus on human cytochrome P450
    Lecointre, K
    Furlan, V
    Taburet, AM
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2002, 16 (06) : 455 - 460
  • [26] Crystal structure of a human cytochrome P450 enzyme
    Jhoti, H
    Williams, P
    Ward, A
    Cosme, J
    DRUG METABOLISM REVIEWS, 2002, 34 : 10 - 10
  • [27] Effect of sinomenine on human cytochrome P450 activity
    Yao, Yong-Mei
    Cao, Wei
    Cao, Ya-Jie
    Cheng, Ze-Neng
    Ou-Yang, Dong-Sheng
    Liu, Zhao-Qian
    Zhou, Hong-Hao
    CLINICA CHIMICA ACTA, 2007, 379 (1-2) : 113 - 118
  • [28] Cytochrome P450: Implications for human breast cancer
    Luo, Bin
    Yan, Dandan
    Yan, Honglin
    Yuan, Jingping
    ONCOLOGY LETTERS, 2021, 22 (01)
  • [29] Metabolism of Evodiamine by Human Cytochrome P450 Enzymes
    Fang, Zhong-Ze
    Yang, Ling
    DRUG METABOLISM REVIEWS, 2009, 41 : 99 - 99
  • [30] In vitro inhibition of human cytochrome P450 by cudratricusxanthone A
    Sim, Juhee
    Choi, Eunhwa
    Lee, You-Mie
    Jeong, Gil-Saeng
    Lee, Sangkyu
    FOOD AND CHEMICAL TOXICOLOGY, 2015, 81 : 171 - 175